Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.3769
-0.0017 (-0.45%)
At close: Jul 11, 2025, 4:00 PM
0.3796
+0.0027 (0.72%)
After-hours: Jul 11, 2025, 6:33 PM EDT

Elevation Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
22332322140-
Upgrade
Market Cap Growth
-93.85%46.03%2.96%-84.16%--
Upgrade
Enterprise Value
-27-39-42-56-16-
Upgrade
Last Close Price
0.380.560.540.956.02-
Upgrade
PB Ratio
0.480.550.420.450.99-
Upgrade
P/TBV Ratio
0.480.550.420.450.99-
Upgrade
Debt / Equity Ratio
0.670.520.550.60--
Upgrade
Quick Ratio
19.0420.8620.055.7516.6411.70
Upgrade
Current Ratio
19.4021.2121.225.9317.0011.91
Upgrade
Return on Equity (ROE)
-78.32%-77.48%-88.03%-100.23%-29.83%-45.78%
Upgrade
Return on Assets (ROA)
-29.86%-30.25%-27.52%-48.50%-17.39%-26.07%
Upgrade
Return on Capital (ROIC)
-30.93%-31.73%-30.86%-53.93%-18.65%-28.63%
Upgrade
Earnings Yield
-214.88%-133.75%-200.66%-429.82%-22.94%-
Upgrade
FCF Yield
-176.87%-109.33%-246.65%-386.83%-21.60%-
Upgrade
Buyback Yield / Dilution
-35.68%-56.82%-56.97%-91.77%-1432.24%-6.43%
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q